2017

BML-277

BML-277 BML-277 is an arylbenzimidazole inhibitor of checkpoint kinase 2 (CHK2). This compound displays cytoprotective activity, protecting CD4+ and CD8+ T cells against radiation-induced apoptosis. References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/18844771 Cas No.…